Access the full text.
Sign up today, get DeepDyve free for 14 days.
A. Hipkiss, Harj Chana (1998)
Carnosine protects proteins against methylglyoxal-mediated modifications.Biochemical and biophysical research communications, 248 1
S. Thorpe, J. Baynes (1996)
Role of the Maillard Reaction in Diabetes Mellitus and Diseases of AgingDrugs & Aging, 9
John Lee, H. Miyawaki, E. Bobst, J. Hester, M. Ashraf, A. Bobst (1999)
Improved functional recovery of ischemic rat hearts due to singlet oxygen scavengers histidine and carnosine.Journal of molecular and cellular cardiology, 31 1
I. Shipanova, M. Glomb, R. Nagaraj (1997)
Protein modification by methylglyoxal: chemical nature and synthetic mechanism of a major fluorescent adduct.Archives of biochemistry and biophysics, 344 1
T. Miyata, S. Sugiyama, D. Suzuki, R. Inagi, K. Kurokawa (1999)
Increased carbonyl modification by lipids and carbohydrates in diabetic nephropathy.Kidney international. Supplement, 71
Boldyrev Boldyrev, Koldobski Koldobski, Kurella Kurella, Maltseva Maltseva, Stvolinski Stvolinski (1993)
Natural histidine‐containing dipeptide carnosine as a potent hydrophilic antioxidant with membrane stabilizing functionMol Chem Neuropathol, 19
Frye Frye, Degenhardt Degenhardt, Thorpe Thorpe, Baynes Baynes (1998)
Role of the Maillard reaction in aging of tissue proteins: advanced glycation endproduct‐dependent increase in imidazolium crosslink in human lens proteinsJ Biol Chem, 273
A. Hipkiss, Viki Worthington, D. Himsworth, Wolker Herwig (1998)
Protective effects of carnosine against protein modification mediated by malondialdehyde and hypochlorite.Biochimica et biophysica acta, 1380 1
A. Hipkiss, J. Michaelis, P. Syrris (1995)
Non‐enzymatic glycosylation of the dipeptide l‐carnosine, a potential anti‐protein‐cross‐linking agentFEBS Letters, 371
Fitzgerald, Swearengin, Yeargans, Mcwhorter, Cucchetti, Seidler (1999)
Non-Enzymatic Glycosylation (or Glycation) and Inhibition of the Pig Heart Cytosolic Aspartate Aminotransferase by Glyceraldehyde 3-Phosphate.Journal of enzyme inhibition, 15 1
Elisabeth Frye, T. Degenhardt, S. Thorpe, J. Baynes (1998)
Role of the Maillard Reaction in Aging of Tissue ProteinsThe Journal of Biological Chemistry, 273
A. Hipkiss, J. Preston, David Himswoth, V. Worthington, N.Joan Abbot (1997)
Protective effects of carnosine against malondialdehyde-induced toxicity towards cultured rat brain endothelial cellsNeuroscience Letters, 238
T. Swearengin, C. Fitzgerald, N. Seidler (1999)
Carnosine prevents glyceraldehyde 3-phosphate-mediated inhibition of aspartate aminotransferaseArchives of Toxicology, 73
S. Kikuchi, K. Shinpo, F. Moriwaka, Z. Makita, T. Miyata, K. Tashiro (1999)
Neurotoxicity of methylglyoxal and 3‐deoxyglucosone on cultured cortical neurons: Synergism between glycation and oxidative stress, possibly involved in neurodegenerative diseasesJournal of Neuroscience Research, 57
H. Masaki, Y. Okano, Hiromu Sakurai (1999)
Generation of active oxygen species from advanced glycation end-products (AGEs) during ultraviolet light A (UVA) irradiation and a possible mechanism for cell damaging.Biochimica et biophysica acta, 1428 1
Jackson Jackson, Lenney Lenney (1996)
The distribution of carnosine and related dipeptides in rat and human tissuesInflamm Res, 45
A. Boldyrev, A. Koldobski, E. Kurella, V. Maltseva, S. Stvolinski (1993)
Natural histidine-containing dipeptide carnosine as a potent hydrophilic antioxidant with membrane stabilizing function. A biomedical aspect.Molecular and chemical neuropathology, 19 1-2
H. Hammes, A. Alt, T. Niwa, J. Clausen, R. Bretzel, M. Brownlee, Erwin Schleicher (1999)
Differential accumulation of advanced glycation end products in the course of diabetic retinopathyDiabetologia, 42
Carbohydrate‐derived aldehydes cause irreversible loss of protein function via glycation. We previously observed that glyceraldehyde 3‐phosphate (Glyc3P) abolishes the enzyme activity of cardiac aspartate aminotransferase (cAAT). We also examined the protective effects of carnosine against Glyc3P‐induced loss of enzyme activity. The present study looked at carnosine’s prevention of Glyc3P‐induced change in protein structure. Purified cAAT (2 mg protein/mL) was incubated with various concentrations of carnosine (1–20 mM) in the presence of Glyc3P (500 μM) for 4 days at 37ºC. Following incubation, samples were analyzed by SDS‐polyacrylamide gel electrophoresis. Carnosine showed prevention of protein modification at carnosine‐to‐Glyc3P ratios of 10:1 or greater. There was a progressive loss of the unmodified cAAT protein band as Glyc3P concentration was increased. Additionally, the gel position of the Glyc3P‐modified cAAT protein varied over time. The apparent molecular weight (MWapp) of the Glyc3P‐modified cAAT protein that formed after 1 day at 37ºC (500 μM) was greater than its MWapp after 2 days, suggesting that a chemical rearrangement of the initial adduct occurs. These observations support the hypothesis that carnosine is an antiglycation agent and that its mechanism of action involves prevention of protein modification. © 2000 John Wiley & Sons, Inc. J Biochem Toxicol 14:215–220, 2000
Journal of Biochemical and Molecular Toxicology (Formerly Journal of Biochemical Toxicology) – Wiley
Published: Jan 1, 2000
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.